Detection of novel carbohydrate binding activity of interleukin-1

被引:13
|
作者
Tandai-Hiruma, M [1 ]
Endo, T [1 ]
Kobata, A [1 ]
机构
[1] Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1080071, Japan
关键词
D O I
10.1074/jbc.274.7.4459
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tamm-Horsfall glycoprotein (THGP) and the oligosaccharide fraction liberated from THGP by hydrazinolysis inhibited tetanus toroid-induced T cell proliferation. Intact THGP showed approximately 100-fold more inhibitory activity than the free oligosaccharides. After fractionating the oligosaccharides by anion-exchange column chromatography, the inhibitory activity could be detected in a sialidase-resistant acidic oligosaccharide fraction (fraction AR). The inhibitory activity of fraction AR was not observed when the fraction was added to the T cell culture medium 24 h after the addition of tetanus toroid. Increased concentration of interleukin (IL) 1 beta and decreased concentration of IL-2 were observed in the T cell culture medium after the addition of fraction AR. The oligosaccharides in fraction AR also inhibited the growth of an IL-1-dependent cell line, D10-G4. These results strongly suggested that the oligosaccharides in fraction AR bind to IL-1 beta and suppress its cytokine activity. IL-1 beta actually bound to the fraction AR immobilized on an amino-bonded thin layer plate. Fractionation of the oligosaccharides indicated that only oligosaccharides containing an N-acetylgalactosamine residue and a sulfate residue bound specifically to IL-1 beta. Removal of either the sulfate residue or the N-acetylgalactosamine residue from the oligosaccharides abolished both the proliferation-inhibition and IL-1 beta binding activities. Since IL-1 beta did not bind to thyroid-stimulating hormone, which has the sulfate group at C-4 of the N-acetylgalactosamine residue in its N-linked sugar chains, the binding of IL-1 beta toward oligosaccharides in fraction AR was considered to be highly specific.
引用
收藏
页码:4459 / 4466
页数:8
相关论文
共 50 条
  • [41] Interleukin-1 beta and GTP-binding proteins
    Sjoholm, A
    [J]. DIABETOLOGIA, 1996, 39 (02) : 243 - 244
  • [42] MODALITIES FOR REDUCING INTERLEUKIN-1 ACTIVITY IN DISEASE
    DINARELLO, CA
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (05) : 155 - 159
  • [43] INTERLEUKIN-1 INHIBITOR - CHARACTERIZATION OF MECHANISM OF ACTIVITY
    BARAK, V
    TREVES, AJ
    [J]. LYMPHOKINE RESEARCH, 1988, 7 (03): : 268 - 268
  • [44] Induction of interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (03) : 981 - 993
  • [45] Interleukin-1 and interleukin-1 fragments as vaccine adjuvants
    Boraschi, D
    Tagliabue, A
    [J]. METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1999, 19 (01): : 108 - 113
  • [46] INTERFERON INHIBITS INTERLEUKIN-1 INDUCTION BY INTERLEUKIN-1
    GHEZZI, P
    DINARELLO, CA
    [J]. JOURNAL OF INTERFERON RESEARCH, 1987, 7 (06): : 827 - 827
  • [47] Interleukin-1β, interleukin-18, and the interleukin-1β converting enzyme
    Dinarello, CA
    [J]. MOLECULAR MECHANISMS OF FEVER, 1998, 856 : 1 - 11
  • [48] DETECTION OF INTERLEUKIN-1 ACTIVITY IN HUMAN BLADDER-CANCER CELL-LINES
    HAYASHI, O
    AKASHI, M
    FUJIME, M
    HANAZAWA, K
    KITAGAWA, R
    [J]. JOURNAL OF UROLOGY, 1994, 151 (03): : 750 - 753
  • [49] Alteration of interleukin-1 alpha production and interleukin-1 alpha binding sites in mouse brain during rabies infection
    Marquette, C
    Ceccaldi, PE
    Ban, E
    Weber, P
    Tsiang, H
    Haour, F
    [J]. ARCHIVES OF VIROLOGY, 1996, 141 (3-4) : 573 - 585
  • [50] HETEROGENEITY OF TYPE-II INTERLEUKIN-1 RECEPTORS - HETEROGENEITY OF B-CELL INTERLEUKIN-1 BINDING CREATED BY DIMERIZATION OF TYPE-II INTERLEUKIN-1 RECEPTORS
    CRONKHITE, RI
    LOBICK, JJ
    PLATE, JMD
    [J]. HUMAN IMMUNOLOGY, 1993, 36 (02) : 128 - 136